Zachary Gaertner

Zachary Gaertner

Auto-generated profile, based on publicly available information

Zachary Gaertner

Northwestern University Feinberg School of Medicine, Dept of Neurology

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Trends in Neurosciences
Verified
Journal Article
Closed access
JPJean-Francois Poulin
Jean-Francois Poulin
ZGZachary Gaertner
Zachary Gaertner
OMOscar Andrés Moreno-Ramos
Oscar Andrés Moreno-Ramos
RARajeshwar Awatramani
Rajeshwar Awatramani

3 August 2023 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
MAMaite Azcorra
Maite Azcorra
ZGZachary Gaertner
Zachary Gaertner
CDConnor Davidson
Connor Davidson
QHQianzi He
Qianzi He
HKHailey Kim
Hailey Kim
DDDaniel A. Dombeck
Daniel A. Dombeck
Dopamine neurons are characterized by their response to unexpected rewards, but they also fire during movement and aversive stimuli. Dopamine neuron diversity has been observed based on molecular expression profiles; however, whether different functions map onto such genetic subtypes remains unclear. In this study, we established that three genetic dopamine neuron subtypes within the substantia nigra pars compacta, characterized by the expression of Slc17a6 (Vglut2), Calb1 and Anxa1, each have a unique set of responses to rewards, aversive stimuli and accelerations and decelerations, and these signaling patterns are highly correlated between somas and axons within subtypes. Remarkably, reward responses were almost entirely absent in the Anxa1+ subtype, which instead displayed acceleration-correlated signaling. Our findings establish a connection between functional and genetic dopamine neuron subtypes and demonstrate that molecular expression patterns can serve as a common framework to dissect dopaminergic functions.

1 June 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
AWAlexander J Willis
Alexander J Willis
SPSebastian P Pernal
Sebastian P Pernal
ZGZachary A. Gaertner
Zachary A. Gaertner
SLSajani S Lakka
Sajani S Lakka
MSMichael E Sabo
Michael E Sabo
HEHerbert H Engelhard
Herbert H Engelhard
Background: Magnetic nanoparticles (MNPs) hold promise for enhancing delivery of therapeutic agents, either through direct binding or by functioning as miniature propellers. Fluid-filled conduits and reservoirs within the body offer avenues for MNP-enhanced drug delivery. MNP clusters can be rotated and moved across surfaces at clinically relevant distances in response to a rotating magnet. Limited data are available regarding issues affecting MNP delivery by this mechanism, such as adhesion to a cellular wall. Research reported here was initiated to better understand the fundamental principles important for successful implementation of rotational magnetic drug targeting (rMDT). Methods: Translational movements of four different iron oxide MNPs were tested, in response to rotation (3 Hz) of a neodymium–boron–iron permanent magnet. MNP clusters moved along biomimetic channels of a custom-made acrylic tray, by surface walking. The effects of different distances and cellular coatings on MNP velocity were analyzed using videography. Dyes (as drug surrogates) and the drug etoposide were transported by rotating MNPs along channels over a 10 cm distance. Results: MNP translational velocities could be predicted from magnetic separation times. Changes in distance or orientation from the magnet produced alterations in MNP velocities. Mean velocities of the fastest MNPs over HeLa, U251, U87, and E297 cells were 0.24 ± 0.02, 0.26 ± 0.02, 0.28 ± 0.01, and 0.18 ± 0.03 cm/sec, respectively. U138 cells showed marked MNP adherence and an 87.1% velocity reduction at 5.5 cm along the channel. Dye delivery helped visualize the effects of MNPs as microdevices for drug delivery. Dye delivery by MNP clusters was 21.7 times faster than by diffusion. MNPs successfully accelerated etoposide delivery, with retention of chemotherapeutic effect. Conclusion: The in vitro system described here facilitates side-by-side comparisons of drug delivery by rotating MNP clusters, on a human scale. Such microdevices have the potential for augmenting drug delivery in a variety of clinical settings, as proposed.

10 October 2017 in IEEE Magnetics Letters
Verified
Journal Article
Closed access
HEHerbert H. Engelhard
Herbert H. Engelhard
SPSebastian P. Pernal
Sebastian P. Pernal
ZGZachary A. Gaertner
Zachary A. Gaertner
ALAdam G. Levin
Adam G. Levin
YPYayue Pan
Yayue Pan
FCFrancis M. Creighton
Francis M. Creighton
Iron oxide nanoparticles (IONs) hold promise for enhancing drug delivery for cancer, stroke, and other diseases. Here, we demonstrate the use of a multiple-lane tissue culture tray and rotating permanent magnet to study magnetically induced rotation and translation (MIRT) of magnetic microbeads (MBs). MBs are nanoparticle aggregates with single-crystalline magnetite cores which can be moved by surface traction. The MIRT tray was produced by additive manufacturing (3-D printing) or subtractive manufacturing (milling) of acrylic. The velocity of MBs in the MIRT tray through phosphate-buffered saline, culture media with fetal bovine serum (FBS), and 100 FBS was measured from 7.5 to 30cm above the rotating magnet. A maximum velocity of greater than 5cms occurred at a distance of 22.5cm. Cultured rabbit aortic endothelial cells, grown in lanes of the sterilized MIRT tray, cause some reduction in MB velocity. We conclude that MBs are easily rotated and moved at physiologic distances by the rotating permanent magnet. Thus, MIRT can potentially be used to direct MBs in clinical drug delivery, and the MIRT tray provides a convenient model system for testing variables which can affect ION movement.

8 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ZGZachary Gaertner
Zachary Gaertner
COCameron Oram
Cameron Oram
ASAmanda Schneeweis
Amanda Schneeweis
ESElan Schonfeld
Elan Schonfeld
CBCyril Bolduc
Cyril Bolduc
RARajeshwar Awatramani
Rajeshwar Awatramani
Several studies have revealed that midbrain dopamine (DA) neurons, even within a single neuroanatomical area, display heterogeneous properties. In parallel, studies using single cell profiling techniques have begun to cluster DA neurons into subtypes based on their molecular signatures. Recent work has shown that molecularly defined DA subtypes within the substantia nigra (SNc) display distinctive anatomic and functional properties, and differential vulnerability in Parkinson’s disease (PD). Based on these provocative results, a granular understanding of these putative subtypes and their alterations in PD models, is imperative. We developed an optimized pipeline for single-nuclear RNA sequencing (snRNA-seq) and generated a high-resolution hierarchically organized map revealing 20 molecularly distinct DA neuron subtypes belonging to three main families. We integrated this data with spatial MERFISH technology to map, with high definition, the location of these subtypes in the mouse midbrain, revealing heterogeneity even within neuroanatomical sub-structures. Finally, we demonstrate that in the preclinical LRRK2 G2019S knock-in mouse model of PD, subtype organization and proportions are preserved. Transcriptional alterations occur in many subtypes including those localized to the ventral tier SNc, where differential expression is observed in synaptic pathways, which might account for previously described DA release deficits in this model. Our work provides an advancement of current taxonomic schemes of the mouse midbrain DA neuron subtypes, a high-resolution view of their spatial locations, and their alterations in a prodromal mouse model of PD. Teaser: Using snRNASeq and MERFISH we identified midbrain DA subtypes, mapped their spatial location, and identified alterations in a LRRK2 model

12 May 2025 in eLife
Verified
Journal Article
Open access
ZGZachary Gaertner
Zachary Gaertner
COCameron Oram
Cameron Oram
ASAmanda Schneeweis
Amanda Schneeweis
ESElan Schonfeld
Elan Schonfeld
CBCyril Bolduc
Cyril Bolduc
RARajeshwar Awatramani
Rajeshwar Awatramani
Several studies have revealed that midbrain dopamine (DA) neurons, even within a single neuroanatomical area, display heterogeneous properties. In parallel, studies using singlecell profiling techniques have begun to cluster DA neurons into subtypes based on their molecular signatures. Recent work has shown that molecularly defined DA subtypes within the substantia nigra (SNc) display distinctive anatomic and functional properties, and differential vulnerability in Parkinson’s disease (PD). Based on these provocative results, a granular understanding of these putative subtypes and their alterations in PD models, is imperative. We developed an optimized pipeline for single-nuclear RNA sequencing (snRNA-seq) and generated a high-resolution hierarchically organized map revealing 20 molecularly distinct DA neuron subtypes belonging to three main families. We integrated this data with spatial MERFISH technology to map, with high definition, the location of these subtypes in the mouse midbrain, revealing heterogeneity even within neuroanatomical sub-structures. Finally, we demonstrate that in the preclinical LRRK2G2019S knock-in mouse model of PD, subtype organization and proportions are preserved. Transcriptional alterations occur in many subtypes including those localized to the ventral tier SNc, where differential expression is observed in synaptic pathways, which might account for previously described DA release deficits in this model. Our work provides an advancement of current taxonomic schemes of the mouse midbrain DA neuron subtypes, a high-resolution view of their spatial locations, and their alterations in a prodromal mouse model of PD.